Atlas Trials

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Clinical trial NCT01089270 · UNKNOWN

Trial details

NCT number
NCT01089270
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Parkinson Disease
Start date
2010-03-01
Primary completion
2011-03-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.